If marijuana is rescheduled—as President Donald Trump directed in a recent executive order—congressional researchers say the ...

The new proposed federal classification of marijuana would allow more research, and would let cannabis businesses take normal ...

The change would not legalize the drug on the federal level, but would ease barriers on research using cannabis.

CHARLESTON, W.Va. — Differing opinions are coming from leaders and advocates in West Virginia regarding President Trump’s new ...

The Republican Party that once gave us the war on drugs and “Just Say No” is getting a little more weed-friendly. President Donald Trump on Thursday signed an executive order to speed the ...

President Trump is expected to sign an order that would reschedule marijuana to a lower drug classification, according to two sources, in one of the most significant changes to drug policy in decades.

President Donald Trump is expected to sign an executive order rescheduling marijuana as a Schedule III drug, placing it on the same level as Tylenol with codeine, testosterone or anabolic steroids.

The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

President Trump's executive order on marijuana's classification could bring changes to Oklahoma On April, President Trump ...

Moving marijuana to Schedule III places in the same category as Tylenol with codeine or anabolic steroids, allowing accepted medical use and a lower potential for abuse while keeping it regulated.

For years, many in the medical and public health communities have anxiously awaited the long-overdue federal Controlled Substances Act reclassification of marijuana to characterize it more accurately.

Earlier this month, President Donald Trump signed an executive order to move marijuana to a Schedule III drug.